查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1996544

心臟瓣膜修復和置換裝置市場：產品類型、組件、最終用戶和銷售管道分類－2026-2032年全球市場預測

Heart Valve Repair & Replacement Devices Market by Product Category, Component, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，心臟瓣膜修復和置換設備市場價值將達到 72 億美元，到 2026 年將成長至 78 億美元，到 2032 年將達到 127 億美元，複合年成長率為 8.43%。

主要市場統計數據
基準年 2025 72億美元
預計年份：2026年 78億美元
預測年份 2032 127億美元
複合年成長率 (%) 8.43%

全面概述了正在重塑心臟瓣膜修復和置換路徑的臨床、技術和商業性趨勢的發展。

心臟瓣膜修復和置換領域正處於關鍵的轉折點，傳統外科手術與經導管技術的快速創新在此交匯融合。影像學、器材設計和手術全期管理的進步正在逐步改變臨床決策流程，並為各個風險等級的患者拓展治療選擇。這項發展反映了心血管醫學的更廣泛變革，包括多學科心臟團隊的建立、更精細的患者篩選標準，以及對長期瓣膜功能和患者生活品質的日益重視。

臨床創新、影像技術的進步以及實證產品開發如何全面改變心臟瓣膜的治療方法和護理途徑。

近年來，我們不僅見證了器械的逐步改進，也見證了突破性變革，這些變革從根本上改變了臨床醫生治療瓣膜疾病的方式。由於輸送系統、密封機制和器械外形等方面的改進，微創經導管技術已從小眾選擇發展成為特定患者群體的主流治療方法，從而減輕了手術負擔並縮短了恢復時間。同時，外科人工瓣膜的進步，包括組織處理和血流動力學最佳化，也不斷提升其在年輕和活躍患者中的應用效果。

本研究評估了近期關稅變化如何影響整個心臟瓣膜設備生態系統的供應鏈、採購實務和策略製造決策。

關稅環境的變化為整個心臟瓣膜器械生態系統的供應鏈設計、籌資策略和價格談判帶來了新的變數。關稅調整正在影響進口零件和組裝器械的成本結構，促使製造商重新評估籌資策略，並考慮近岸外包、供應商多元化或垂直整合以降低風險。這些應對措施正在影響前置作業時間、庫存持有成本以及與醫療保健採購方的合約義務。

詳細的細分分析揭示了手術和經導管裝置路徑、組織來源和修復方法如何定義臨床和商業性差異。

將心臟瓣膜市場細分，可清楚展現影響產品開發和商業化策略的技術路徑和臨床決策樹。在考慮置換療法時，市場可分為外科手術和經導管兩種方式。外科手術置換仍以機械瓣膜和生物瓣膜的選擇為主要區別，而生物瓣膜可進一步細分為同種異體移植瓣膜、支架瓣膜和無支架瓣膜。支架瓣膜通常來自牛心包和豬組織。經導管置換則透過專用輸送系統和針對特定解剖部位，進一步細分為多個領域。這包括經導管主動脈瓣置換術、經導管二尖瓣置換術和經導管肺動脈瓣置換術，每種系統都有其獨特的器械設計限制和臨床終點。

區域部署模式和進入趨勢將決定監管、支付方和臨床基礎設施如何影響心臟瓣膜裝置在全球市場的商業化。

地理因素在心臟瓣膜技術的部署模式、監管路徑和商業模式中起著決定性作用。美洲擁有完善的介入治療基礎設施和活躍的臨床試驗活動，這有利於微創技術的快速普及和全面的上市後數據的收集。該地區的支付方在評估新器械時，越來越重視長期價值和療效比較的證據。歐洲、中東和非洲（EMEA）地區的監管環境和報銷機制各不相同，這兩個地區的器械普及率都很高，且市場依賴集中採購，醫院預算有限。在全部區域，定價策略和衛生技術評估（HTA）的結果對市場准入時間有顯著的影響。

競爭與合作的動態動態，結合成熟的外科技術、敏捷的創新與策略夥伴關係，塑造了我們的市場領導地位。

心臟瓣膜領域的競爭格局呈現出兩極化的態勢：既有歷史悠久的醫療器材巨頭，也有專注於經導管和修復技術的敏捷創新者。成熟的醫療設備製造商在規模、監管專業知識和長期臨床資料集方面擁有優勢，這些優勢能夠支持其產品在醫療機構中的應用，而耐用性和可靠的性能仍然是關鍵考慮因素。這些企業通常利用涵蓋組織處理、人工瓣膜工程和全球分銷網路的綜合產品組合，為臨床教育和多市場推廣提供支援。

透過整合證據產生、供應鏈彈性、臨床醫生培訓和模組化技術設計，加速推廣應用和商業性成功的實用建議。

領導者應優先考慮整合策略，將臨床證據的獲取與可擴展的商業營運和穩健的供應鏈結合。首先，投資於可靠的真實世界證據（RWE）項目，作為主要臨床試驗的補充，記錄長期療效、患者報告結局（PRO）以及在不同臨床環境下的療效比較。此類證據為與支付方對話奠定了基礎，並有助於建立有利的報銷途徑。其次，透過多元化的供應商網路和區域生產能力，在製造和採購方面追求柔軟性，降低關稅和物流風險，同時保持品質和成本競爭力。

為了提供實際的見解，我們採用了一種高度透明的調查方法，結合了對臨床醫生的初步訪談、文獻整合、醫療設備核准途徑圖繪製以及供應鏈風險評估。

本研究整合了透過對臨床醫生、醫療設備工程師、監管專家和採購經理進行結構化訪談收集的一手和二手證據，並輔以對同行評審的臨床文獻和手術註冊資料的分析。一手研究著重於對手術決策、醫療設備選擇標準和推廣障礙的定性分析，而二手資訊則提供了關於技術趨勢、監管先例和不斷演變的臨床指南的背景資訊。在調查方法方面，本研究優先採用多資訊來源檢驗，以確保每個主題結論的可靠性，並減少單一資訊來源觀點所帶來的偏差。

結論闡述了綜合證據、營運韌性和策略商業化如何決定心臟瓣膜治療領域的長期領導地位。

心臟瓣膜疾病的治療和置換領域正邁入一個更為複雜的時代，器械創新、臨床證據和系統層面的經濟因素相互交織，共同決定哪些技術能夠成功。隨著經導管技術的擴展和外科人工瓣膜的不斷發展，耐久性、再次干預途徑及其與以患者為中心的治療結果之間的相互作用，將日益影響治療方法的選擇。相關人員，將更有能力影響臨床實踐並獲得長期價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：心臟瓣膜修復和置換器械市場（按產品類型）

  • 維修裝置
    • 瓣環成形術
      • 手術環/帶
      • 經導管環瓣環成形術
    • 球囊瓣環成形/瓣葉切開術
    • 索狀韌帶修復
    • 傳單修復
    • 閥門周圍洩漏的封閉
    • 經導管瓣膜邊緣修復術（TEER）
      • 二尖瓣TER
      • 三尖瓣TEER
  • 更換閥門
    • 再手術解決方案
      • Valve-In-MAC
      • Valve-In-Ring
      • 閥中閥
    • 外科瓣膜置換術
      • 生物瓣膜
      • 附支架
      • 防鏽的
      • 無需縫合/快速部署
      • 機械閥
    • 經導管瓣膜置換術
      • 主動脈瓣（TAVR）
      • 二尖瓣（TMVR）
      • 肺動脈瓣（TPVR）
      • 三尖瓣（TTVR）

第9章 心臟瓣膜修復與置換器械市場：依組件分類

  • 配件
    • 栓塞預防裝置
    • 成像導管
    • 導入器/鞘套
    • 可轉向導軌
  • 配送系統
  • 植入

第10章：心臟瓣膜修復與置換器械市場：依最終用戶分類

  • 門診手術中心
  • 心臟導管檢查室
  • 醫院
    • 區域醫院/二級醫療機構
    • 三級和四級醫療中心
  • 專業心臟病中心

第11章：心臟瓣膜修復與置換器械市場：依銷售管道分類

  • 直銷
  • 透過分銷商銷售
  • 集團採購組織
  • 在線/採購門戶

第12章 心臟瓣膜修復與置換器械市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：心臟瓣膜修復與置換器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 心臟瓣膜修復和置換器械市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國心臟瓣膜修復與置換器械市場

第16章：中國心臟瓣膜修復與置換器械市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Braile Biomedica
  • Corcym
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Peijia Medical Limited
  • Sahajanand Medical Technologies Limited
  • Terumo Corporation
  • TTK Healthcare Limited
  • Venus Medtech（Hangzhou）Inc.
Product Code: MRR-925E8149CC89

The Heart Valve Repair & Replacement Devices Market was valued at USD 7.20 billion in 2025 and is projected to grow to USD 7.80 billion in 2026, with a CAGR of 8.43%, reaching USD 12.70 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.20 billion
Estimated Year [2026] USD 7.80 billion
Forecast Year [2032] USD 12.70 billion
CAGR (%) 8.43%

A comprehensive introduction to the evolving clinical, technological, and commercial dynamics reshaping heart valve repair and replacement pathways

The field of heart valve repair and replacement stands at a pivotal inflection point where surgical tradition intersects with rapid transcatheter innovation. Advances in imaging, device design, and perioperative management have progressively shifted clinical decision-making pathways, expanding therapeutic options for patients across risk spectra. This evolution reflects broader changes in cardiovascular care, including multidisciplinary heart teams, refined patient selection criteria, and a stronger emphasis on long-term valve performance and quality of life.

Clinicians and health systems now evaluate valve interventions not only through the lens of acute procedural success but also by durability, need for reintervention, and implications for future transcatheter access. As a result, technology developers and device manufacturers are prioritizing modularity, ease of deployment, and compatibility with valve-in-valve strategies. Concurrently, regulatory authorities and payers are increasingly focused on real-world evidence and comparative effectiveness, shaping the pathway for commercialization and reimbursement.

Taken together, these elements create a dynamic landscape in which clinical needs, technological capability, and commercial imperatives interact. Stakeholders that understand these dynamics and align product development, clinical evidence generation, and market access strategies will be best positioned to influence care pathways and capture opportunities arising from the shifting treatment paradigm.

How clinical innovation, imaging advances, and evidence-driven commercialization are collectively transforming heart valve treatment modalities and care pathways

Recent years have delivered transformative shifts that extend beyond incremental device improvements to alter how clinicians approach valve disease entirely. Minimally invasive transcatheter techniques have matured from niche options to mainstream therapies for certain patient groups, driven by improvements in delivery systems, sealing mechanisms, and device profiles that reduce procedural trauma and recovery time. At the same time, refinements in surgical prostheses, including tissue processing and hemodynamic optimization, continue to elevate performance for younger and more active patients.

Technology convergence has accelerated progress. Enhanced imaging modalities, computational modeling, and intra-procedural guidance systems now enable precision planning and device placement that reduce variability in outcomes. These tools foster higher confidence in treating complex anatomies, which expands the population eligible for less invasive approaches. Furthermore, the emphasis on valve durability and the management of reintervention pathways has intensified efforts to develop device platforms that support staged therapies, including valve-in-valve or hybrid approaches.

On the commercial front, strategic partnerships between device innovators and established clinical networks expedite the translation of new technologies into practice. Evidence generation strategies have evolved to include robust registries and pragmatic trials that capture longitudinal performance in routine care. Collectively, these shifts create a more competitive, evidence-driven environment where the ability to demonstrate clinical value, streamline adoption, and ensure long-term patient benefit determines success.

Assessing how recent tariff changes reshape supply chains, procurement behavior, and strategic manufacturing decisions across the heart valve device ecosystem

The tariff landscape has introduced new variables for supply chain design, procurement strategies, and pricing negotiations across the heart valve device ecosystem. Tariff adjustments influence cost structures for imported components and assembled devices, prompting manufacturers to reassess sourcing strategies and consider nearshoring, supplier diversification, or vertical integration to mitigate exposure. These responses have implications for lead times, inventory carrying costs, and contractual commitments with healthcare purchasers.

Clinician demand and hospital purchasing cycles respond to subtle shifts in total cost of ownership, particularly when tariff-induced price changes affect devices used routinely in high-volume centers. Hospitals and health systems may increase scrutiny of procurement decisions, demand clearer value propositions, and prioritize vendors that can demonstrate supply resilience and transparent pricing. In parallel, regulatory submissions and tender processes may require updated cost-effectiveness documentation that reflects changed input costs.

Beyond immediate procurement effects, tariffs can accelerate strategic consolidation among suppliers and trigger geographic repositioning of manufacturing capacity. For newer entrants, tariff volatility elevates the strategic importance of manufacturing flexibility and local clinical partnerships to support market entry. Meanwhile, established incumbents with diversified production footprints can leverage scale and logistics sophistication to maintain competitive advantage. Overall, tariff dynamics add a layer of operational complexity that requires proactive scenario planning and agile commercial execution.

Deep segmentation analysis revealing how surgical and transcatheter device pathways, tissue sourcing, and repair modalities define clinical and commercial differentiation

Segmenting the heart valve market illuminates distinct technology pathways and clinical decision trees that influence product development and commercialization strategies. When considering replacement therapies, the market divides into surgical and transcatheter approaches. Surgical replacement remains differentiated by mechanical and tissue valve options, with tissue valves further subdivided into homografts, stented and stentless designs; stented constructs commonly draw on bovine pericardial and porcine tissue sources. Transcatheter replacement introduces another axis of segmentation through dedicated delivery systems and anatomic targets, covering transcatheter aortic replacement, transcatheter mitral replacement, and transcatheter pulmonary replacement systems, each with unique device design constraints and clinical endpoints.

Repair therapies constitute a parallel but equally nuanced landscape. Surgical repair includes annuloplasty rings, chordal replacement devices, and valve reshaping technologies, where annuloplasty rings are themselves classified by flexibility characteristics into flexible, rigid, and semi-rigid designs, and chordal replacement options range from autologous pericardial reconstructions to synthetic chordae. The transcatheter repair domain has emerged with distinct system classes such as annuloplasty systems and leaflet approximation technologies like clip and alternative leaflet devices; within annuloplasty systems, commercially prominent approaches include band and loop-like solutions tailored to percutaneous anatomy.

Understanding these segmentation pathways clarifies clinical value propositions, regulatory evidence needs, and manufacturing implications. For example, tissue sourcing and processing impact durability narratives for surgical constructs, while delivery catheter design and anchoring strategies drive development priorities for transcatheter platforms. Similarly, the distinctions between repair and replacement inform reimbursement positioning and training requirements for implanting centers. Segment-aware strategies therefore enable developers and commercial teams to align R&D investments with procedural realities and payer expectations.

Regional adoption patterns and access dynamics that determine how regulatory, payer, and clinical infrastructures shape heart valve device commercialization across global markets

Geographic dynamics play a decisive role in adoption patterns, regulatory pathways, and commercial models for heart valve technologies. The Americas exhibit advanced interventional infrastructure and strong clinical trial activity, supporting rapid uptake of minimally invasive techniques and robust post-market data collection; payers in this region increasingly seek evidence of long-term value and comparative effectiveness when evaluating new devices. Europe, Middle East & Africa presents a heterogeneous regulatory and reimbursement landscape where high-adoption pockets coexist with markets that depend on centralized procurement and constrained hospital budgets; pricing strategies and health technology assessment outcomes strongly influence market access timelines across this region.

Asia-Pacific demonstrates diverse maturity across national health systems, with several markets showing rapid adoption driven by large patient populations and growing capacities in tertiary centers. In some countries within Asia-Pacific, local manufacturing and partnerships with regional clinical networks accelerate entry, while in others, regulatory harmonization and infrastructure build-out remain focal areas. Across all regions, differences in procedural volumes, clinician training pathways, and public versus private healthcare delivery models shape how technologies are introduced and scaled.

Regional insights underscore that a one-size-fits-all commercial approach will underdeliver. Instead, successful market strategies anticipate local regulatory requirements, adapt clinical evidence packages to regional payer expectations, and tailor training and service models to the operational realities of implanting centers. Cross-border partnerships, local clinical champions, and flexible supply models are instrumental in translating innovation into sustained regional adoption.

Competitive and collaborative dynamics that combine established surgical prowess with nimble innovation and strategic partnerships to shape market leadership

Competitive dynamics in the heart valve space reflect a mix of long-established surgical leaders and agile innovators focused on transcatheter and repair technologies. Incumbent surgical device manufacturers maintain strengths in scale, regulatory expertise, and long-term clinical datasets that underpin adoption in centers where durability and proven performance remain primary considerations. These organizations often leverage comprehensive portfolios that span tissue processing, prosthesis engineering, and global distribution networks to support clinical education and multi-market rollouts.

At the same time, smaller and more focused companies drive disruptive progress by concentrating on delivery systems, sealing technologies, and mechanisms that expand anatomical suitability for less invasive approaches. These firms frequently collaborate with academic centers to generate early clinical evidence and refine device iterations quickly through iterative learning. Strategic alliances and licensing agreements between innovators and larger firms are common as each side seeks complementary capabilities, whether in manufacturing scale, regulatory navigation, or market access execution.

Service and training ecosystems are also pivotal competitive assets. Providers who offer robust clinician training, simulation, and proctoring support accelerate procedural adoption and reduce variability in outcomes, thereby enhancing the commercial proposition. As adoption patterns shift, organizations that combine technical excellence with scalable clinician support and evidence generation capabilities will secure durable positions in clinical pathways.

Actionable recommendations that integrate evidence generation, supply chain resilience, clinician training, and modular technology design to accelerate adoption and commercial success

Leaders should prioritize integrated strategies that align clinical evidence generation with scalable commercial operations and resilient supply chains. First, invest in robust, real-world evidence programs that complement pivotal trials by documenting long-term performance, patient-reported outcomes, and comparative effectiveness in diverse clinical settings; such evidence underpins payer dialogues and supports favorable reimbursement pathways. Second, pursue manufacturing and sourcing flexibility through diversified supplier networks and regional production capacities to mitigate tariff and logistics risks while preserving quality and cost competitiveness.

Third, cultivate deep clinical partnerships and training infrastructure to accelerate safe adoption, reduce procedural variability, and foster local champions who can articulate device value within their networks. Fourth, design modular platforms and interoperable delivery systems that facilitate staged therapies and simplify inventory management for hospital systems; modularity also enhances the ability to iterate device lifecycles without disrupting established procedural workflows. Finally, adopt sophisticated pricing strategies that reflect total cost of care implications and support outcomes-based contracting where appropriate to address payer priorities and demonstrate value over time.

By executing on these interconnected priorities, industry leaders can convert technical advances into sustainable clinical adoption and commercial success while remaining responsive to evolving regulatory and payer environments.

Transparent research methodology combining primary clinician interviews, literature synthesis, device pathway mapping, and supply chain risk assessment to support actionable insights

This research synthesizes primary and secondary evidence gathered through structured interviews with clinicians, device engineers, regulatory specialists, and procurement leaders, supplemented by analysis of peer-reviewed clinical literature and procedural registries. Primary research emphasized qualitative insights into procedural decision-making, device selection criteria, and adoption barriers, while secondary sources provided context on technological trends, regulatory precedents, and clinical guideline evolution. The methodology prioritized triangulation across input types to ensure the robustness of thematic conclusions and to reduce bias associated with single-source perspectives.

Analytical approaches included device pathway mapping, clinical outcome triangulation, and supply chain risk assessment. Device pathway mapping linked design attributes to procedural workflows and training needs, whereas outcome triangulation compared early clinical reports with registry data to identify consistent performance signals. Supply chain assessments evaluated sourcing concentration, logistics dependencies, and potential tariff impacts on cost and lead time. Wherever possible, findings were validated through follow-up discussions with domain experts to refine interpretation and test scenario plausibility.

The resulting synthesis focuses on actionable implications rather than predictive estimates, enabling stakeholders to apply insights directly to strategic planning, product development prioritization, and market entry sequencing. Transparency in methods supports reproducibility and allows clients to request deeper dives into specific segments or geographies as needed.

Concluding perspective on how integrated evidence, operational resilience, and strategic commercialization will define long-term leadership in heart valve therapies

The heart valve repair and replacement domain is transitioning to a more nuanced era where device innovation, clinical evidence, and system-level economics jointly determine which technologies succeed. As transcatheter techniques expand and surgical prostheses continue to evolve, the interplay between durability, reintervention pathways, and patient-centered outcomes will increasingly drive therapeutic choices. Stakeholders who integrate rigorous evidence generation with agile manufacturing and targeted regional strategies will be best positioned to influence clinical practice and capture long-term value.

Operational resilience and deliberate commercialization approaches matter now more than ever. Tariff dynamics and supply chain complexities require proactive planning, while competitive differentiation depends on demonstrating real-world benefits that resonate with clinicians, payers, and health system leaders. Companies that invest in clinician training, scalable service models, and modular device platforms will reduce barriers to adoption and support broader procedural diffusion.

Ultimately, sustained leadership in this space will come from organizations that balance scientific rigor with commercial pragmatism, anchoring product strategies in demonstrable patient benefit while ensuring that logistical and economic considerations support reliable, affordable access to care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Heart Valve Repair & Replacement Devices Market, by Product Category

  • 8.1. Repair Devices
    • 8.1.1. Annuloplasty
      • 8.1.1.1. Surgical Rings/Bands
      • 8.1.1.2. Transcatheter Annuloplasty
    • 8.1.2. Balloon Valvuloplasty/Commissurotomy
    • 8.1.3. Chordal Repair
    • 8.1.4. Leaflet Repair
    • 8.1.5. Paravalvular Leak Closure
    • 8.1.6. Transcatheter Edge-To-Edge Repair (TEER)
      • 8.1.6.1. Mitral TEER
      • 8.1.6.2. Tricuspid TEER
  • 8.2. Replacement Valves
    • 8.2.1. Redo Solutions
      • 8.2.1.1. Valve-In-MAC
      • 8.2.1.2. Valve-In-Ring
      • 8.2.1.3. Valve-In-Valve
    • 8.2.2. Surgical Valve Replacement
      • 8.2.2.1. Bioprosthetic Valves
      • 8.2.2.1.1. Stented
      • 8.2.2.1.2. Stentless
      • 8.2.2.1.3. Sutureless/Rapid-Deployment
      • 8.2.2.2. Mechanical Valves
    • 8.2.3. Transcatheter Valve Replacement
      • 8.2.3.1. Aortic (TAVR)
      • 8.2.3.2. Mitral (TMVR)
      • 8.2.3.3. Pulmonary (TPVR)
      • 8.2.3.4. Tricuspid (TTVR)

9. Heart Valve Repair & Replacement Devices Market, by Component

  • 9.1. Accessories
    • 9.1.1. Embolic Protection Devices
    • 9.1.2. Imaging Catheters
    • 9.1.3. Introducers/Sheaths
    • 9.1.4. Steerable Guides
  • 9.2. Delivery System
  • 9.3. Implant

10. Heart Valve Repair & Replacement Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Catheterization Labs
  • 10.3. Hospitals
    • 10.3.1. Community/Secondary Hospitals
    • 10.3.2. Tertiary/Quaternary Centers
  • 10.4. Specialty Heart Centers

11. Heart Valve Repair & Replacement Devices Market, by Sales Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales
  • 11.3. Group Purchasing Organization
  • 11.4. Online/Procurement Portals

12. Heart Valve Repair & Replacement Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Heart Valve Repair & Replacement Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Heart Valve Repair & Replacement Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Heart Valve Repair & Replacement Devices Market

16. China Heart Valve Repair & Replacement Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Boston Scientific Corporation
  • 17.7. Braile Biomedica
  • 17.8. Corcym
  • 17.9. CryoLife, Inc.
  • 17.10. Edwards Lifesciences Corporation
  • 17.11. JenaValve Technology, Inc.
  • 17.12. Lepu Medical Technology (Beijing) Co., Ltd.
  • 17.13. LivaNova PLC
  • 17.14. Medtronic plc
  • 17.15. Meril Life Sciences Pvt. Ltd.
  • 17.16. MicroPort Scientific Corporation
  • 17.17. Peijia Medical Limited
  • 17.18. Sahajanand Medical Technologies Limited
  • 17.19. Terumo Corporation
  • 17.20. TTK Healthcare Limited
  • 17.21. Venus Medtech (Hangzhou) Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL RINGS/BANDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL RINGS/BANDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL RINGS/BANDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER ANNULOPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER ANNULOPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER ANNULOPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BALLOON VALVULOPLASTY/COMMISSUROTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BALLOON VALVULOPLASTY/COMMISSUROTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BALLOON VALVULOPLASTY/COMMISSUROTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CHORDAL REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY LEAFLET REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY LEAFLET REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY LEAFLET REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PARAVALVULAR LEAK CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PARAVALVULAR LEAK CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PARAVALVULAR LEAK CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL TEER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL TEER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL TEER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID TEER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID TEER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID TEER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-MAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-MAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-MAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-RING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-RING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-RING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-VALVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-VALVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY VALVE-IN-VALVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STENTLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUTURELESS/RAPID-DEPLOYMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUTURELESS/RAPID-DEPLOYMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUTURELESS/RAPID-DEPLOYMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AORTIC (TAVR), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AORTIC (TAVR), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AORTIC (TAVR), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL (TMVR), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL (TMVR), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY MITRAL (TMVR), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PULMONARY (TPVR), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PULMONARY (TPVR), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PULMONARY (TPVR), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID (TTVR), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID (TTVR), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRICUSPID (TTVR), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMAGING CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMAGING CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMAGING CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY INTRODUCERS/SHEATHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY INTRODUCERS/SHEATHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY INTRODUCERS/SHEATHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STEERABLE GUIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STEERABLE GUIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY STEERABLE GUIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DELIVERY SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DELIVERY SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DELIVERY SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY CARDIAC CATHETERIZATION LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMMUNITY/SECONDARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMMUNITY/SECONDARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMMUNITY/SECONDARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TERTIARY/QUATERNARY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TERTIARY/QUATERNARY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TERTIARY/QUATERNARY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SPECIALTY HEART CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SPECIALTY HEART CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SPECIALTY HEART CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP PURCHASING ORGANIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP PURCHASING ORGANIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY GROUP PURCHASING ORGANIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ONLINE/PROCUREMENT PORTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ONLINE/PROCUREMENT PORTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ONLINE/PROCUREMENT PORTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REDO SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SURGICAL VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY BIOPROSTHETIC VALVES, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER VALVE REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPAIR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY ANNULOPLASTY, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY TRANSCATHETER EDGE-TO-EDGE REPAIR (TEER), 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET SIZE, BY REPLACEMENT VALVES, 2018-2032 (USD MILLION)

TA